TSND-201 produced statistically significant placebo-adjusted improvements in PTSD severity.
The executive order dramatically affects research priorities, regulatory momentum, investment, and adoption.
Read morePsychedelics in 2026
Here’s an opinion piece on what to look out for with psychedelics in 2026!
Read morePTSD and Psychedelics
FDA rejects MDMA-Assisted Therapy for PTSD
Big news for MDMA-assisted therapy. Here are a couple takes on it:
https://themicrodose.substack.com/p/breaking-news-federal-regulators
https://psychedelicinvest.com/fda-denies-lykos-and-requests-another-trial/
F.D.A. Panel Votes Against MDMA-Assisted Therapy for PTSD
The Food and Drug Administration’s Psychopharmacologic Drugs Advisory Committee voted overwhelmingly to reject MDMA-assisted therapy in the treatment of post traumatic stress disorder, or PTSD.
The FDA will issue its final decision on the matter in mid-August but in the majority of cases, the federal agency’s decisions align with the vote of the independent panelists on advisory committees.
Read moreMDMA Trials for PTSD Facing Setbacks?
Two articles cover this recent update.
npr: Misconduct claims may derail MDMA psychedelic treatment for PTSD
Axios: Landmark review spotlights challenge of judging psychedelic therapies
Read morePsychedelics for Soldiers with Trauma
Research suggests that the psychedelic drug MDMA, an empathogenic stimulant also known as Molly or ecstasy, can spark changes in the brain that induce a childlike state of neuroplasticity and help forge new neural connections.
(It could well be approved for PTSD by the U.S. Food and Drugs Administration in August after two advanced stage trials showed significant benefits.)
Researchers are also studying other psychedelics as well, like the powerful drug ibogaine.
Read moreMDMA for PTSD
MDMA therapy for PTSD could become a new treatment option for millions of people living with trauma. The clinical evidence is growing.
Read morePsychedelics, Alcoholism and PTSD
Future clinical trials should determine whether psychedelic-assisted therapy holds promise for individuals with complex trauma and alcohol misuse who have not been successfully treated with traditional interventions.
Read moreMDMA-Assisted Therapy and PTSD
Here’s the official statement from MAPS!
The results confirmed findings from MAPP1; no serious adverse events were observed among the participants
In a first for psychedelic-assisted therapy trials, more than half of MAPP2 participants identify as people of color
Iboga for PTSD for Vets
Veterans are turning to psychedelic treatments for PTSD healing.
Read more